{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChange": 0.0, "regularMarketTime": 1683871252, "regularMarketDayHigh": 10.3, "regularMarketDayRange": "10.3 - 10.3", "regularMarketDayLow": 10.3, "regularMarketVolume": 5000, "regularMarketPreviousClose": 10.3, "bid": 10.3, "ask": 11.3, "fullExchangeName": "Frankfurt", "financialCurrency": "CNY", "regularMarketOpen": 10.3, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 1.6000004, "fiftyTwoWeekLowChangePercent": 0.18390809, "fiftyTwoWeekRange": "8.7 - 19.8", "fiftyTwoWeekHighChange": -9.499999, "fiftyTwoWeekHighChangePercent": -0.47979796, "fiftyTwoWeekLow": 8.7, "fiftyTwoWeekHigh": 19.8, "exchange": "FRA", "shortName": "WUXI BIOLOGICS UNSP.ADR/2", "longName": "WuXi Biologics (Cayman) Inc.", "messageBoardId": "finmb_431763406", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 10.3, "trailingAnnualDividendRate": 0.0, "trailingPE": 39.615387, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 0.26, "sharesOutstanding": 2112630016, "bookValue": 16.59, "fiftyDayAverage": 11.267, "fiftyDayAverageChange": -0.967, "fiftyDayAverageChangePercent": -0.08582586, "twoHundredDayAverage": 13.071, "twoHundredDayAverageChange": -2.771, "twoHundredDayAverageChangePercent": -0.21199602, "marketCap": 23638603776, "priceToBook": 0.6208559, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1618552800000, "priceHint": 2, "symbol": "1FW1.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 108, Meiliang Road", "address2": "Mashan", "city": "Wuxi", "zip": "214092", "country": "China", "website": "https://www.wuxibiologics.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development, and manufacturing in the People's Republic of China, North America, Europe, and internationally. It also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and material supplier activities. The company was incorporated in 2014 and is headquartered in Wuxi, China.", "fullTimeEmployees": 12373, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ge  Li Ph.D.", "age": 55, "title": "Founder & Chairman", "yearBorn": 1967, "fiscalYear": 2021, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Zhisheng  Chen", "age": 49, "title": "CEO & Exec. Director", "yearBorn": 1973, "fiscalYear": 2021, "totalPay": {"raw": 654807, "fmt": "654.81k", "longFmt": "654,807"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Weichang  Zhou Ph.D.", "age": 58, "title": "Pres of Global Biologics Devel. & Operations, CTO and Exec. Director", "yearBorn": 1964, "fiscalYear": 2021, "totalPay": {"raw": 378535, "fmt": "378.54k", "longFmt": "378,535"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ming  Tu", "age": 54, "title": "CFO & Exec. VP", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Tang  Shaogui M.B.A.", "title": "VP and Head of Global Communications, Operations & ESG", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jijie  Gu", "age": 56, "title": "Exec. VP & Chief Scientific Officer", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Eileen  Wang", "title": "IR Sr. Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Cong  Ding J.D.", "title": "VP & Head of Legal Department", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "He  Wang", "title": "Chief Compliance Officer, Sr. VP & Head of Global Compliance and Risk Management", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Li  Xiong", "title": "VP & Head of Global HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 3, "boardRisk": 10, "compensationRisk": 3, "shareHolderRightsRisk": 4, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}